MetaCap

Alcon (ALC) vs National Vision (EYE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Alcon (ALC) has outperformed National Vision (EYE) over the past year, losing 3.0% versus a loss of 37.1%. Over five years, ALC leads with a -4.6% price change compared with -65.0% for EYE. Alcon is the larger company by market cap ($35.70 billion vs $1.31 billion), about 27.3 times the size, while National Vision is growing revenue faster (+9.0% vs +4.9%).

On valuation, National Vision trades at a lower forward P/E (14.3x vs 19.1x for Alcon). Alcon pays a dividend yielding 0.48%, while National Vision does not currently pay one. Alcon converts more of its revenue into profit, with a net margin of 9.4% versus 1.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ALC-3.00%EYE-37.12%
+17%-14%-45%
Nov 21, 20251 yearNov 20, 2026
ALC-9.84%EYE-65.64%
+26%-30%-85%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ALC versus EYE key metrics
MetricALCEYE
Share price$74.31$16.72
Market cap$35.70B$1.31B
1-day change-0.26%-1.70%
YTD return-5.71%-35.24%
1-year return-3.00%-37.12%
5-year return-4.62%-65.00%
P/E ratio (TTM)54.2420.39
Forward P/E19.0514.31
EPS (TTM)$1.37$0.82
Dividend yield0.48%0.00%
Annual dividend$0.353$0.00
Revenue (latest FY)$10.40B$1.99B
Revenue growth (YoY)+4.94%+9.00%
Net income (latest FY)$980.00M$29.60M
Gross margin55.24%58.77%
Operating margin13.08%2.96%
Net margin9.42%1.49%
52-week high$87.64$30.02
52-week low$61.84$14.75
Distance from 52-week high-15.21%-44.30%
Analyst consensusbuybuy
Avg. price target upside+9.37%+61.48%
Average volume2.01M2.14M
Shares outstanding480.40M78.07M
Employees25,00013,138
SectorHealth CareHealth Care
IndustryOphthalmic GoodsOphthalmic Goods

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Alcon is about 27.3 times larger than National Vision by market value ($35.70B vs $1.31B).
  • ALC has outperformed EYE by 34.1 percentage points over the past year.
  • Alcon trades at a higher earnings multiple (54.2x vs 20.4x trailing P/E).
  • Alcon is more profitable, keeping 9.4 cents of every revenue dollar as net income versus 1.5 cents for National Vision.

About Alcon

ALC stock →

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.

Health Care · Ophthalmic Goods · 25,000 employees

About National Vision

EYE stock →

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com.

Health Care · Ophthalmic Goods · 13,138 employees

ALC vs EYE FAQ

Which is bigger, Alcon or National Vision?

Alcon (ALC) is larger, with a market capitalization of $35.70B compared with $1.31B for National Vision (EYE).

Which stock has performed better over the past year, ALC or EYE?

ALC returned -3.00% over the past 12 months, compared with -37.12% for EYE (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ALC or EYE?

EYE has the lower trailing P/E at 20.4, versus 54.2 for ALC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Alcon or National Vision?

Alcon pays a dividend yielding 0.48%, while National Vision does not currently pay a regular dividend.

Are Alcon and National Vision in the same industry?

Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.

More comparisons